NCT01462890
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
- Locations
-
- Aalborg, Denmark
- Copenhagen, Denmark
- Herlev, Denmark
- Kuopio, Finland
Clinical trial condition
Fallopian Tube Neoplasms
Explore clinical trials studying Fallopian Tube Neoplasms. Study availability and eligibility vary by location and protocol.
37 public trials
7 recruiting studies
Fallopian Tube Neoplasms trial results
NCT03593681
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Adnexal Mass, +26 more
- Locations
-
- Scripps Clinic Medical Group San Diego, California, United States
- Kaiser Permanente San Francisco Medical Center San Francisco, California, United States
- Mayo Clinic Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT00391118
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +21 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liège, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Düsseldorf, Germany
Completed
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
NCT02658214
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +58 more
- Locations
-
- Research Site Chūōku, Japan
- Research Site Kashiwa, Japan
- Research Site Seoul, South Korea
- Research Site Seoul, South Korea
NCT01478685
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +49 more
- Locations
-
- Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
- University of California, San Francisco San Francisco, California, United States
- Indiana University Cancer Center Indianapolis, Indiana, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
NCT01846611
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
- Locations
-
- Birmingham, Alabama, United States
- Phoenix, Arizona, United States
- Scottsdale, Arizona, United States
- Sedona, Arizona, United States
Completed
Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy
NCT02786524
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +28 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
NCT00443196
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +23 more
- Locations
-
- Southeastern Gynecologic Oncology Atlanta, Georgia, United States
NCT02444195
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +19 more
- Locations
-
- University of Michigan Cancer Center Ann Arbor, Michigan, United States
NCT00112086
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
- Locations
-
- National Cancer Center Tsukiji, 5-1-1, Chuo-ku, Tokyo, Japan